GSA Capital Partners »

Summit Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $361k 17k 21.28
2025-03-31 $302k 16k 19.30
2024-12-31 $687k 39k 17.85
2022-12-31 $53k 13k 4.24